Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP545921.RA5gvIEFeW0i0mrw4RpH38wma4rFIMtsETDqobYKx817g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP545921.RA5gvIEFeW0i0mrw4RpH38wma4rFIMtsETDqobYKx817g130_assertion type Assertion NP545921.RA5gvIEFeW0i0mrw4RpH38wma4rFIMtsETDqobYKx817g130_head.
- NP545921.RA5gvIEFeW0i0mrw4RpH38wma4rFIMtsETDqobYKx817g130_assertion wasGeneratedBy ECO_0000203 NP545921.RA5gvIEFeW0i0mrw4RpH38wma4rFIMtsETDqobYKx817g130_provenance.
- NP545921.RA5gvIEFeW0i0mrw4RpH38wma4rFIMtsETDqobYKx817g130_assertion wasDerivedFrom befree-20150227 NP545921.RA5gvIEFeW0i0mrw4RpH38wma4rFIMtsETDqobYKx817g130_provenance.
- NP545921.RA5gvIEFeW0i0mrw4RpH38wma4rFIMtsETDqobYKx817g130_assertion SIO_000772 14633710 NP545921.RA5gvIEFeW0i0mrw4RpH38wma4rFIMtsETDqobYKx817g130_provenance.
- NP545921.RA5gvIEFeW0i0mrw4RpH38wma4rFIMtsETDqobYKx817g130_assertion evidence source_evidence_literature NP545921.RA5gvIEFeW0i0mrw4RpH38wma4rFIMtsETDqobYKx817g130_provenance.
- NP545921.RA5gvIEFeW0i0mrw4RpH38wma4rFIMtsETDqobYKx817g130_assertion description "[Antitumor effects of a soluble form dominant negative of the type I insulin-like growth factor receptor (IGF-IR) designated as 486/STOP were evaluated in CaOV-3 human ovarian cancer cells by establishing stable transformants overexpressing 486/STOP and by administration of 486/STOP recombinant protein.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP545921.RA5gvIEFeW0i0mrw4RpH38wma4rFIMtsETDqobYKx817g130_provenance.